全文获取类型
收费全文 | 1442篇 |
免费 | 77篇 |
国内免费 | 47篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 8篇 |
妇产科学 | 3篇 |
基础医学 | 192篇 |
口腔科学 | 3篇 |
临床医学 | 49篇 |
内科学 | 55篇 |
皮肤病学 | 2篇 |
神经病学 | 535篇 |
特种医学 | 19篇 |
外科学 | 22篇 |
综合类 | 114篇 |
预防医学 | 29篇 |
眼科学 | 5篇 |
药学 | 377篇 |
中国医学 | 137篇 |
肿瘤学 | 13篇 |
出版年
2023年 | 8篇 |
2022年 | 15篇 |
2021年 | 32篇 |
2020年 | 17篇 |
2019年 | 29篇 |
2018年 | 26篇 |
2017年 | 30篇 |
2016年 | 24篇 |
2015年 | 25篇 |
2014年 | 37篇 |
2013年 | 77篇 |
2012年 | 69篇 |
2011年 | 76篇 |
2010年 | 52篇 |
2009年 | 37篇 |
2008年 | 69篇 |
2007年 | 65篇 |
2006年 | 45篇 |
2005年 | 40篇 |
2004年 | 40篇 |
2003年 | 60篇 |
2002年 | 33篇 |
2001年 | 56篇 |
2000年 | 26篇 |
1999年 | 24篇 |
1998年 | 22篇 |
1997年 | 31篇 |
1996年 | 23篇 |
1995年 | 22篇 |
1994年 | 23篇 |
1993年 | 17篇 |
1992年 | 29篇 |
1991年 | 28篇 |
1990年 | 22篇 |
1989年 | 20篇 |
1988年 | 23篇 |
1987年 | 17篇 |
1986年 | 27篇 |
1985年 | 39篇 |
1984年 | 33篇 |
1983年 | 28篇 |
1982年 | 32篇 |
1981年 | 36篇 |
1980年 | 24篇 |
1979年 | 17篇 |
1978年 | 10篇 |
1977年 | 7篇 |
1976年 | 4篇 |
1974年 | 6篇 |
1973年 | 5篇 |
排序方式: 共有1566条查询结果,搜索用时 15 毫秒
1.
本文报道用高效液相色谱-电化学检测器方法,研究了罂粟碱对大鼠脑内及心脏单胺神经递质代谢的影响。结果表明:罂粟碱能显著增加大鼠纹状体及边缘区多巴胺代谢物二羟苯乙酸(DOPAC)和高香草酸(HVA),升高约50-70%。5-羟色胺代谢物5-羟吲哚醋酸(5HIAA)增加约30%,而对脑及心脏内的单胺递质本身含量未见有明显影响。 相似文献
2.
I. Hilakivi L. Ahtee J. O. Rinne T. Taira L. M. J. Attila P. Marjamäki 《Journal of neural transmission (Vienna, Austria : 1996)》1995,102(2):139-148
Summary Rats were treated with desipramine 5mg/kg, nomifensine 10mg/kg, zimelidine 25 mg/kg or with 0.9% sodium chloride once a day during the second and third weeks after birth, and brain stem, caudate/putamen and cortical monoamines, and caudate/putamen dopamine D1 (3[H]SCH 23390) and D2 (3[H]spiroperidol) receptor binding were measured when rats were at two months of age. In the brain stem, the concentration of 3-methoxy-4-hydroxy-phenyl glycol was increased in nomifensine rats and the ratio of 5-hydroxyindoleacetic acid to 5-hydroxytryptamine was increased in zimelidine rats. In the caudate/putamen, the concentrations of 3,4-dihydroxyphenylacetic acid and homovanillic acid and the ratio of homovanillic acid to dopamine were increased in desipramine rats; neither3[H]SCH 23390 nor3[H]spiroperidol binding were affected by any of the three monoamine uptake inhibiting antidepressants studied. In the cortex, the ratio of 5-hydroxyindoleacetic acid to 5-hydroxytryptamine was increased in desipramine and zimelidine rats. The findings suggest that desipramine but not nomifensine increases the metabolism of dopamine in the caudate/ putamen and nomifensine but not desipramine increases the metabolism of norepinephrine in the brain stem, and furthermore that the metabolism of serotonin is affected by desipramine as well as by zimelidine. It is possible that also treatment of women with these drugs during late pregnancy causes long-lasting changes in the brain of human fetus. 相似文献
3.
Juraj Sprung MD PhD David Distel CRNA Jeffrey Grass MD Eric L. Bloomfield MD Ian C. Lavery MD 《Journal of clinical anesthesia》1996,8(8):662-665
We describe a patient in whom long-term monoamine oxidase (MAO) inhibitor therapy was discontinued 20 days before surgery with general anesthesia. This patient developed severe perioperative hypotension after administration of 10 mg of bupivacaine through an epidural catheter, which was corrected only after potent vasopressor therapy. We attribute this hemodynamic instability to attenuation of this patient's sympathetic tone based on several mechanisms: (1) residual effect of long-term administration of MAO inhibitor that caused a decrease in the number of β-adrenergic receptors (adrenergic subsensitivity due to receptor down-regulation), (2) recovered MAO activity causing effective degradation of sympathetic amines, and (3) combined attenuating effects of general and epidural anesthesia on sympathetic tone. 相似文献
4.
A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action. 总被引:2,自引:0,他引:2
P Ken Gillman 《Neuropsychopharmacology》2006,59(11):1046-1051
Data now exist from which an accurate definition for serotonin toxicity (ST), or serotonin syndrome, has been developed; this has also lead to precise, validated decision rules for diagnosis. The spectrum concept formulates ST as a continuum of serotonergic effects, mediated by the degree of elevation of intrasynaptic serotonin. This progresses from side effects through to toxicity; the concept emphasizes that it is a form of poisoning, not an idiosyncratic reaction. Observations of the degree of ST precipitated by overdoses of different classes of drugs can elucidate mechanisms and potency of drug actions. There is now sufficient pharmacological data on some drugs to enable a prediction of which ones will be at risk of precipitating ST, either by themselves or in combinations with other drugs. This indicates that some antidepressant drugs, presently thought to have serotonergic effects in animals, do not exhibit such effects in humans. Mirtazapine is unable to precipitate serotonin toxicity in overdose or to cause serotonin toxicity when mixed with monoamine oxidase inhibitors, and moclobemide is unable to precipitate serotonin toxicity in overdose. Tricyclic antidepressants (other than clomipramine and imipramine) do not precipitate serotonin toxicity and might not elevate serotonin or have a dual action, as has been assumed. 相似文献
5.
本文从下丘脑、大脑皮层、海马等脑区去甲肾上腺素(NA)的含量,其合成酶与降解酶的活性、NA受体数目等多环节的测定来分析肾上腺素能神经递质系统在老化脑中的变化。实验结果表明衰老过程下丘脑、大脑皮层内NA合成酶活性没变化,NA含量明显增高,下丘脑内α_1受体数目显著减少。上述结果提示这些脑区肾上腺素能神经的活动有可能减弱。同时,海马内单胺氧化酶B(MAO B)活性明显增加,说明海马神经元外组织有增生的可能。泰文并讨论了这些变化与老年记忆、行为与神经内分泌等脑功能衰退的关系。 相似文献
6.
用荧光分光光度法检测了血清单胺氧化酶(MAO)同工酶A(MAO-A)和同工酶B(MAO-B)活性,结果表明血清MAO-B活性急性期甲肝组较正常对照组显著升高,慢性期乙肝极显著升高;二型肝炎组的MAO-A活性升高程度无统计学意义。二型肝炎MAO同工酶活性改变与其它肝功生化指标无明显相关性,表现血清MAO同工酶活性与肝功损害程度不相关。 相似文献
7.
Toshikazu Saito M.D. Hideaki Ishizawa M.D. Fumiaki Tsuchiya M.D. Hiroki Ozawa M.D. Naohiko Takahata M.D. 《Psychiatry and clinical neurosciences》1986,40(2):189-194
Abstract: Monoamine and their acid metabolites were determined in the CSF of 18 drug-treated chronic schizophrenic patients with the symptoms of tardive dyskinesia and neuroleptic-induced Parkinsonism (Parkinsonism). Six healthy volunteers were used as the control group.
The norepinephrine (NE) levels were found to be significantly higher in the patients with tardive dyskinesia than in the controls. Furthermore, elevated CSF NE levels were also observed in the patients with Parkinsonism. Epinephrine (E) and Dopamine (DA) were not present in the CSF of the control group, whereas measurable levels of DA could be detected in 4 out of 9 and E was found in 8 out of 9 patients with tardive dyskinesia. The mean concentration of HVA was slightly but not significantly elevated in the patients with tardive dyskinesia and Parkinsonism. The mean values of CSF 5-HIAA were all within the normal range in both patient groups. From the above results, it was suggested that abnormal adrenergic activity rather than abnormal dopaminergic activity may play an important role as a mechanism in the etiopathogenesis of extrapyramidal disorders. Furthermore, in the patients with Parkinsonism, CSF neurochemical observations were similar to those of the patients with tardive dyskinesia in this study. It may help to explain the clinical coexistence of tardive dyskinesia and neuroleptic-induced Parkinsonism. 相似文献
The norepinephrine (NE) levels were found to be significantly higher in the patients with tardive dyskinesia than in the controls. Furthermore, elevated CSF NE levels were also observed in the patients with Parkinsonism. Epinephrine (E) and Dopamine (DA) were not present in the CSF of the control group, whereas measurable levels of DA could be detected in 4 out of 9 and E was found in 8 out of 9 patients with tardive dyskinesia. The mean concentration of HVA was slightly but not significantly elevated in the patients with tardive dyskinesia and Parkinsonism. The mean values of CSF 5-HIAA were all within the normal range in both patient groups. From the above results, it was suggested that abnormal adrenergic activity rather than abnormal dopaminergic activity may play an important role as a mechanism in the etiopathogenesis of extrapyramidal disorders. Furthermore, in the patients with Parkinsonism, CSF neurochemical observations were similar to those of the patients with tardive dyskinesia in this study. It may help to explain the clinical coexistence of tardive dyskinesia and neuroleptic-induced Parkinsonism. 相似文献
8.
J. J. M. Askenasy MD. PhD. M. D. Yahr 《Journal of neural transmission (Vienna, Austria : 1996)》1988,72(1):67-76
Summary In the present study a single case observation of myoclonus during sleep-wave transition was monitored in a depressed patient treated with the monoamine oxidase inhibitor, phenelzine. The myoclonus had a rhythm of 1 c/second and lasted for two years, the duration of phenelzine treatment. Myoclonus appeared neither during wakefulness nor during sleep, but at wake-sleep-wake transitions. This switch myoclonus was associated with phasic muscle hyperactivity during REM sleep.Methysergide a 5-HT suppressor, decreased the switch myoclonus frequency and the REM muscle hyperactivity, indicating serotoninergic involvement in the mechanism of phenelzine induced myoclonus. 相似文献
9.
S. Turkish P. H. Yu A. J. Greenshaw 《Journal of neural transmission (Vienna, Austria : 1996)》1988,74(3):141-148
Summary A behavioural test involving potentiation of the effects of an acute injection of -phenylethylamine (10 mg kg–1 i.p.) was used to assess the time-course of type-B MAO inhibition after administration of (–)deprenyl (5 mg kg–1 i.p.) and of MD 240928 (20 mg kg–1 i.p.) respectively. Potentiation of the effects of -phenylethylamine was observed 1 h after injection of (–)deprenyl or MD 240928. This effect was still evident 120 h after administration of (–)deprenyl but not 24 h after administration of MD 240928. Comparisons of ex vivo estimates of MAO activity yielded a corresponding time-course for the recovery of this enzyme. The extent of MAO inhibition required for potentiation of the effects of -phenylethylamine was inferred from a comparison of the behavioural test results and the ex vivo MAO activity observed after (–)deprenyl administration. These comparisons indicate a significant underestimation of MD 240928-induced MAO inhibition using ex vivo measures. This underestimation is interpreted as evidence fordilution effects in the ex vivo assay of MAO inhibition. The potentiation of effects of -phenylethylamine under the present conditions is proposed as a useful and simple test for effects of reversible type-B MAO inhibitors. 相似文献
10.
Summary The handling of five amines by the extraneuronal deaminating system was studied in perfused hearts of rats (pretreated with reserpine; COMT and neuronal uptake inhibited). Hearts were perfused with 50 nmol/l 3H-noradrenaline for 30 min, in the presence of increasing concentrations of unlabelled (–)-adrenaline, (–)-noradrenaline, dopamine, tyramine and 5-HT. IC50's were determined as those concentrations of unlabelled amines which halved the steady-state rate of deamination of 3H-noradrenaline. After correction for changes in the tissue/medium ratio for 3H-noradrenaline, half-saturating outside concentrations were obtained. They increased in the order (–)-adrenaline (15 mol/l) — tyramine — dopamine — noradrenaline —5-HT (53 mol/l). The V
max for extraneuronal deamination was determined for 3H-(–)-adrenaline, 3H-(–)-noradrenaline and 3H-dopamine, as well as (by HPLC and electrochemical detection) for tyramine and 5-HT. It was low for (–)-adrenaline, intermediate for (–)-noradrenaline, dopamine and 5-HT, high for tyramine. For the three catecholamines the half-saturating outside concentrations of the extraneuronal deaminating system clearly exceeded those for the extraneuronal O-methylating system of the same organ (see Grohmann and Trendelenburg 1985), although the two enzymes appear to co-exist in the same cells, so that the same transport system is involved.Abbreviations COMT
catechol-O-methyl transferase
- DOMA
dihydroxymandelic acid
- DOPEG
dihydroxyphenylglycol
- 5-HT
5-hydroxytryptamine
- MAO
monoamine oxidase
Supported by the Deutsche Forschungsgemeinschaft (SFB 176)
Send offprint requests to U. Trendelenburg 相似文献